Building on our values, Lilly embraces the principles of good corporate governance, implemented through strong, independent and diverse membership on our board of directors.
Over the years, we have consistently sought to implement best governance practices. In today's climate of concern over corporate accountability, it is more important than ever that we continually earn investor confidence. We will do this by remaining a leader in corporate governance and providing clear, consistent and truthful communication about our performance.
By selecting the links below, you can access information about our executive committee, corporate governance principles, other key corporate governance information and our annual report and proxy statement. For copies of these documents, call The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979).
Executive Committee
Board of Directors
Board of Directors Committee Membership
Member
|
Audit Committee
|
Talent and Compensation Committee
|
Directors and Corporate Governance Committee
|
Ethics and Compliance Committee
|
Science and Technology Committee
|
|---|---|---|---|---|---|
| Audit Committee: | Talent and Compensation Committee: | Directors and Corporate Governance Committee: | Ethics and Compliance Committee: | Science and Technology Committee: | |
|
Audit Committee:
Member
|
Talent and Compensation Committee:
Chair
| Directors and Corporate Governance Committee: | Ethics and Compliance Committee: | Science and Technology Committee: | |
| Audit Committee: | Talent and Compensation Committee: | Directors and Corporate Governance Committee: |
Ethics and Compliance Committee:
Chair
|
Science and Technology Committee:
Member
| |
| Audit Committee: |
Talent and Compensation Committee:
Member
| Directors and Corporate Governance Committee: | Ethics and Compliance Committee: |
Science and Technology Committee:
Member
| |
| Audit Committee: | Talent and Compensation Committee: | Directors and Corporate Governance Committee: |
Ethics and Compliance Committee:
Member
|
Science and Technology Committee:
Member
| |
|
Audit Committee:
Chair
| Talent and Compensation Committee: |
Directors and Corporate Governance Committee:
Member
| Ethics and Compliance Committee: | Science and Technology Committee: | |
| Audit Committee: |
Talent and Compensation Committee:
Member
| Directors and Corporate Governance Committee: |
Ethics and Compliance Committee:
Member
| Science and Technology Committee: | |
| Audit Committee: | Talent and Compensation Committee: |
Directors and Corporate Governance Committee:
Member
| Ethics and Compliance Committee: |
Science and Technology Committee:
Chair
| |
| Audit Committee: |
Talent and Compensation Committee:
Member
|
Directors and Corporate Governance Committee:
Chair
| Ethics and Compliance Committee: | Science and Technology Committee: | |
|
Audit Committee:
Member
| Talent and Compensation Committee: |
Directors and Corporate Governance Committee:
Member
| Ethics and Compliance Committee: | Science and Technology Committee: | |
|
Audit Committee:
Member
|
Talent and Compensation Committee:
Member
| Directors and Corporate Governance Committee: | Ethics and Compliance Committee: | Science and Technology Committee: |
Committee Membership & Charters
Annual Report & Proxy Statement
About Lilly